Cogentus Pharmaceuticals is a company focused on developing prescription pharmaceutical products in North America and Europe.
Business Model:
Revenue: $0
Employees: 11-50
Address:
City: Menlo Park
State: California
Zip:
Country: United States
Cogentus Pharmaceuticals, Inc., a pharmaceutical company, develops prescription pharmaceutical products in North America and Europe. It develops CGT-2168, an oral formulation that combines clopidogrel with a gastroprotectant, which reduces the gastrointestinal side effects associated with dual antiplatelet therapy. The company was founded in 2006 and is based in Menlo Park, California. On January 16, 2009, Cogentus Pharmaceuticals, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Northern District of California.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2007 | Series C | 4 | $62.5M |
Apothecary Capital Pinnacle Ventures Prospect Venture Partners The Keffi Group Apothecary Capital Pinnacle Ventures Prospect Venture Partners The Keffi Group |
5/2006 | Series A | 1 | - |
Prospect Venture Partners Prospect Venture Partners |
4/2007 | Series B | 1 | $15M |
Prospect Venture Partners Prospect Venture Partners |
5/2006 | Series A | 1 | - |
Prospect Venture Partners Prospect Venture Partners |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|